⌘K

Login Start Free

Home/Filings/4/0001104659-19-037264

4//SEC Filing

SIEBERT JOHN M 4

Accession 0001104659-19-037264

CIK 0001356576other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 8:06 PM ET

Size

6.5 KB

Accession

0001104659-19-037264

Insider Transaction Report

Form 4

Period: 2019-06-20

SUPERNUS PHARMACEUTICALS, INC.SUPN

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to Buy)
2019-06-20−10,000→ 0 total
Exercise: $9.13From: 2016-03-03Exp: 2025-03-03→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2019-06-20$9.13/sh+10,000$91,300→ 55,742 total

Documents

1 file

4
a4.xmlPrimary
4

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1

filerCIK 0001190558

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 8:06 PM ET
Size: 6.5 KB

View on SEC.gov